News | March 24, 2026
Japan okays new long-acting eye drug
It promises fewer injections for vision loss patients
It promises fewer injections for vision loss patients
Call it a major breakthrough for diagnostic imaging
The Silver Medal recognizes strong performance across sustainability, ethics, environment, labour & human rights, and responsible procurement
The pharmaceutical segment led growth, generating Rs. 337 crore in revenue, while the crop protection business contributed Rs. 157 crore
The company reported profit before tax of Rs.67 crore, up sharply from Rs.21 crore in the same period last year
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
The company reported Q3 total income of Rs. 1,005 million, marking a 10.2% increase year-on-year
The approval follows robust data from the SWIFT and ANCHOR Phase III trials
The drug had previously received orphan drug designation for this rare cancer on March 31, 2025
Finerenone is the first therapy targeting the mineralocorticoid receptor pathway to demonstrate cardiovascular benefits in heart failure patients
Subscribe To Our Newsletter & Stay Updated
